A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers

Clinical trial NCT01495065 · TERMINATED

Trial details

NCT number: NCT01495065
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Community-acquired Infection

Start date: 2011-12-19
Primary completion: 2012-02-17
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.